Previous AngIV analogs, while showing promise in animal models of dementia, were hindered by poor metabolic stability indicated by a short half-life, and an inability to cross the BBB due to their peptide nature
Peptides work at the cellular level to enhance your bodys natural repair and regeneration processes, providing more comprehensive and long-lasting results than treatments that only address surface-level concerns
Some are commercially available and are standardized as to effectiveness
Excessive NAM depletion directly reduces the substrate supply for NAD+ synthesis, leading to decreased intracellular NAD+ levels
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and increased by 2.5 mg every 4 weeks up to a maintenance dose of 5-15 mg based on tolerability and therapeutic response
The chemical name is 5,6-dimethyl-benzimidazolyl cyanocobamide